Picture of Shanghai MicroPort MedBot (Group) logo

2252 — Shanghai MicroPort MedBot (Group) News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid Cap

Brief: Shanghai Microport Medbot Says Transperineal Prostate Biopsy System Obtained Approval

May 18 (Reuters) - Shanghai MicroPort MedBot Group
 2252.HK :
    * ISR'OBOT MONA LISA ROBOTIC TRANSPERINEAL PROSTATE BIOPSY
SYSTEM
OBTAINED APPROVAL
    * APPROVAL GIVEN BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION
OF
CHINA

Further company coverage:  2252.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Shanghai MicroPort MedBot (Group)

See all news